| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/10/2004 | CN1481390A Immunomodulatory peptidesderived from heat shock proteins and uses thereof |
| 03/10/2004 | CN1481385A Process for formulation of antibiotic compounds |
| 03/10/2004 | CN1481377A Cyclic Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF alhpa |
| 03/10/2004 | CN1481373A 1,5-benzothiazepines compounds and its use as antilipemic agent |
| 03/10/2004 | CN1481368A Gyrase imhibitors and uses thereof |
| 03/10/2004 | CN1481367A Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 03/10/2004 | CN1481366A Dihydroindole and tetrahydroquinoline derivatives |
| 03/10/2004 | CN1481364A Urea and urethane derivatives as integrin inhibitors |
| 03/10/2004 | CN1481253A Drugs and foods improving quality of life and process for producng same |
| 03/10/2004 | CN1481251A Combined method for treating viral infections |
| 03/10/2004 | CN1481250A Improved and stable extract from hypericum perforatuml, method for prodn thereof |
| 03/10/2004 | CN1481249A 治疗hiv的方法 Hiv treatment methods |
| 03/10/2004 | CN1481245A 2-amino-benzoxazinones for treatment of herpes simplex virus |
| 03/10/2004 | CN1481242A Pharmaceutical formulation contg thienopyrimidines and antithrombotics, calcium-antagonists, prostaglandins or prostaglandin derivatives |
| 03/10/2004 | CN1480461A Metching substance with flavone contained in erigeron breviscapus as ligand and its usage |
| 03/10/2004 | CN1480218A Medicinal preparation of slowly-released bioactive substance, its prepn. and application |
| 03/10/2004 | CN1480217A Medicinal preparation and its prepn. and application |
| 03/10/2004 | CN1480214A Vaccinum contg saponin and sterol |
| 03/10/2004 | CN1480213A Effect of transfer factor and substance of small peptides restraining SARS virus fully |
| 03/10/2004 | CN1480209A Method for producing compound preparation of propolis |
| 03/10/2004 | CN1480207A Spore of gandoderma lucidum for treating disease of autoimmunity |
| 03/10/2004 | CN1480194A Oral liquid for anti SARS virus |
| 03/10/2004 | CN1480193A Kuhseng targeting preparation and its preparing method |
| 03/10/2004 | CN1480192A Medication for treating cancer and chronic hepatitis B and its prepn. method |
| 03/10/2004 | CN1480187A Medication for treating impetigo |
| 03/10/2004 | CN1480177A Preparation to be taken after being mixed with boiling water for easy to release symptom of cough and asthma caused by SARS and its prepn. method |
| 03/10/2004 | CN1480171A Preparation for fish gold and its preparing method |
| 03/10/2004 | CN1480169A Ointment for treating beriberi and its preparing method |
| 03/10/2004 | CN1480153A Tinea cruris ointment |
| 03/10/2004 | CN1480152A 聚甲酚磺醛喷雾剂 Policresulen sprays |
| 03/10/2004 | CN1480149A Antifebrile, antiphlogistic and antiviral capsule |
| 03/10/2004 | CN1480145A Multilayer tablet and multicolor capsule of compound Sulphamethoxazole |
| 03/10/2004 | CN1480137A Osmotic pump type controlled release preparation of kurarinone and its preparing method |
| 03/10/2004 | CN1480134A Combination of iodine amino acid as well as its preparation method and application |
| 03/10/2004 | CN1141317C Cyelosporin derivatives with anti-HIV effect |
| 03/10/2004 | CN1141315C Three-chain formed oligonucleotide capable of inhibiting platelet derived growth factor gene expression and its application |
| 03/10/2004 | CN1141314C 2',3'-O-isopropylidennucleoside 5'-thiophosphamino acid ester compound |
| 03/10/2004 | CN1141312C 15-membered lactams ketolides with antibacterial activity |
| 03/10/2004 | CN1141130C Medicine for treating tonsillitis and its prepn. process |
| 03/10/2004 | CN1141129C Medicine for treating hepatitis B virus |
| 03/10/2004 | CN1141128C Compound oyster shell liquid |
| 03/10/2004 | CN1141120C Liquid medicine for treating influenza virus and its prepn process |
| 03/10/2004 | CN1141116C Powdered medicine for treating pulmonary tuberculosis |
| 03/10/2004 | CN1141102C Kelarmycin eye drops and its preparing process |
| 03/10/2004 | CN1141099C Antibacterial cephalosporin composition |
| 03/10/2004 | CN1141089C Antimicrobials |
| 03/09/2004 | US6703506 Amino acid ester containing azole antifungals |
| 03/09/2004 | US6703490 Amphiphilic complexes, method for their preparation and compositions containing them |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/09/2004 | US6703404 Nitric oxide synthase inhibitors |
| 03/09/2004 | US6703403 Method for improving pharmacokinetics |
| 03/09/2004 | US6703402 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 03/09/2004 | US6703397 Pyrimidinyl methyl indole derivatives with antibacterial activity |
| 03/09/2004 | US6703387 Inhibitors of HPV E1 helicase enzyme |
| 03/09/2004 | US6703372 Macrolides |
| 03/09/2004 | US6703233 Used for stabilizing expression plasmids for use in a genetic vaccine; removes sole dependence on catalytic balanced lethal maintenance system, incorporates a plasmid partition system preventing random segregation of plasmids |
| 03/09/2004 | US6703231 gM-negative EHV-mutants |
| 03/09/2004 | US6703225 Having high specific activity, and a gene thereof, as well as medical uses; eg. for hepatitis and cancer |
| 03/09/2004 | US6703053 For therapy |
| 03/09/2004 | US6703052 Long chain monounsaturated alcohol mixtures |
| 03/09/2004 | US6703046 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
| 03/09/2004 | US6703039 Reversible gelling system for ocular drug delivery |
| 03/09/2004 | CA2408198C Pharmaceutical composition comprising cefuroxime axetil |
| 03/09/2004 | CA2260016C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 03/09/2004 | CA2138793C Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections |
| 03/09/2004 | CA2052229C Antifungal composition in a dry powdered spray form |
| 03/05/2004 | CA2437690A1 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 03/04/2004 | WO2004018683A1 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine |
| 03/04/2004 | WO2004018681A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 03/04/2004 | WO2004018503A1 Template-fixed peptidomimetics with antibacterial activity |
| 03/04/2004 | WO2004018496A1 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 03/04/2004 | WO2004018484A1 Beta-lactamase inhibitor prodrug |
| 03/04/2004 | WO2004018473A2 Azapurine derivatives |
| 03/04/2004 | WO2004018463A2 Pyridyl substituted heterocycles useful for treating or preventing hcv infection |
| 03/04/2004 | WO2004018461A2 Antibacterial benzoic acid derivatives |
| 03/04/2004 | WO2004018458A1 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 03/04/2004 | WO2004018453A1 Proline derivatives |
| 03/04/2004 | WO2004018451A1 Pyridazinone-derivatives as pde4 inhibitors |
| 03/04/2004 | WO2004018439A1 Novel antibacterial agents |
| 03/04/2004 | WO2004018434A1 Pyrimidine compounds |
| 03/04/2004 | WO2004018431A2 Novel phenanthridines |
| 03/04/2004 | WO2004018428A1 Antibacterial benzoic acid derivatives |
| 03/04/2004 | WO2004018425A1 N-4-piperidinyl compounds as ccr5 modulators |
| 03/04/2004 | WO2004018414A2 Antibacterial agents |
| 03/04/2004 | WO2004018412A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 03/04/2004 | WO2004018058A2 Compounds, compositions, and methods |
| 03/04/2004 | WO2004017962A2 Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 03/04/2004 | WO2004017950A2 Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
| 03/04/2004 | WO2004017949A2 Prophylaxis and treatment of infectious diseases |
| 03/04/2004 | WO2004017940A2 Pharmaceutically active lipid based formulation of sn38 |
| 03/04/2004 | WO2004017911A2 Protease inhibitors |
| 03/04/2004 | WO2004017810A2 Tumor specific oligosaccharide epitopes and use thereof |
| 03/04/2004 | WO2004005264A3 Imidazole compounds for the treatment of hepatitis c virus infections |
| 03/04/2004 | WO2003106456A3 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
| 03/04/2004 | WO2003103577A3 Novel recombinant anticoagulant proteins |
| 03/04/2004 | WO2003097871A8 Marker molecules associated with lung tumors |
| 03/04/2004 | WO2003097091A3 Glucan-based vaccines |
| 03/04/2004 | WO2003094960A3 Mucosal combination vaccines for bacterial meningitis |
| 03/04/2004 | WO2003082350A3 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 03/04/2004 | WO2003082216A9 Neuroprotectant methods, compositions, and screening methods thereof |